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Clinical diagnosis
is an art that
depends on creating
likelihoods for a list
of diagnoses.ometime in the fall of 2008, I overheard a conversation regarding the recently
administered cardiology board exam. The commentary expressed concern that
there was too much emphasis on the electrocardiography (ECG) portion of the
xam. The new cardiologist was mainly interested in imaging and felt that the exam
ontent had little relevance to the skill in reading ECGs.
While my career has taken me through the experimental animal laboratory, the exer-
ise laboratory, the catheterization laboratory, and the heart failure and transplant ser-
ice, I have always maintained an outpatient practice where the ECG, a stethoscope,
hysical examination, and patient history were the key elements of patient diagnosis and
anagement.
We used imaging studies to confirm or rule out a list of diagnostic choices in an al-
eady established differential diagnosis list or to determine whether one therapy or an-
ther would be a better choice. Generally, the most likely diagnosis was determined, the
herapy choice made, and if the clinical data were assembled correctly, the images and
ther laboratory studies were confirmatory.
Clinical diagnosis is an art that depends on creating likelihoods for a list of diagnoses.
t is an art based on formal learning, data from guidelines and practice standards, experi-
nce, an understanding of the incidence of disease in the population that your patient
epresents, the relationship of symptoms to specific disease states, and the likelihood of a
isease being present in a specific patient.
For example, a husband and wife saw me in the office to review their laboratory stud-
es. Her studies reported a prostate-specific antigen. Upon questioning, I discovered that
hey were both in the blood laboratory at the same time. From that, I can surmise with
igh certainty that the names were switched on the labels. Should I repeat all the labo-
atory studies? By comparing this year’s studies to their laboratory studies from the pre-
ious year, I could readily ascertain which current studies were hers and which belonged
o him. Was there a risk in assuming these values were switched? Will clinical care be
isdirected? Would they get billed by their insurance company for quickly repeated lab-
ratory studies? By tying all of the information together, I was able to manage their car-
iovascular disease and avoid having to ask them to delay a vacation trip to repeat the
tudies.
We in cardiology are being accused of overutilization of imaging. The accusation
omes from a number of sources (1) and is based on data showing that the rate of
rowth in cardiovascular imaging exceeds the rate of growth in other imaging areas in
edicine. The growth in imaging continues to increase the cost of health care.
We counter that imaging has improved the quality of our care and has saved lives,
nd that the value of reduced mortality and morbidity and restored productivity ex-
eeds the cost of the imaging. After all, cardiology imaging is a small proportion of
ll imaging studies done in the U.S., so why does cardiovascular use get singled out
or criticism?
c
C
c
T
r
a
w
r
b
m
r
r
m
m
e
•
•
•
c
c
c
C
o
s
t
p
p
p
t
f
n
a
t
a
e
p
c
e
f
t
i
p
o
a
d
w
l
t
i
l
t
f
i
a
c
c
b
w
a
l
m
t
w
c
o
p
t
t
a
s
e
A
A
A
2
W
R
1
2
3
1731JACC Vol. 53, No. 18, 2009 Bove
May 5, 2009:1730–1 President’s PageMedicare statistics indicate that cardiovascular disease
onsumes almost one-half of the Medicare budget.
learly this area becomes a target for cost reduction be-
ause of its significant impact on Medicare spending.
hus, we have seen reductions in echocardiography (echo)
eimbursement through bundling of echo services. Now,
lthough no data are yet available, nuclear imaging studies
ere recently reviewed. We can probably guess that the
esult will be some reduction in reimbursement that will
e announced in the fall of 2009, leaving us little time to
odify practice budgets for 2010.
How do you think cardiovascular professionals should
espond? My opening comments provide a hint of my
esponse to that question. I believe that we are relying too
uch on imaging data and numerical results of testing in
anaging patients with heart disease. A paper by Vergh-
se (2) describes the problem of house officers who:
direct their attention to images and numbers on a
computer screen;
pay little attention to making a direct evaluation of the
patient’s problems; and
do not take the time to understand the broader context
of the complaint or disorder.
To help us change this pattern of practice, the Ameri-
an College of Cardiology is developing appropriate use
riteria not just for imaging, but also for therapeutic pro-
edures. The first is the 2009 Appropriateness Criteria for
oronary Revascularization (3). These criteria are based
n a combination of clinical information and study re-
ults. They demand a thorough understanding of the pa-
ient’s medical status and history in order to properly ap-
ly the criteria in clinical scenarios.
Similar assumptions are inherent in the use of clinical
ractice guidelines. These documents are also meant to be
ractice aids to apply the current knowledge from clinical
rials and expert consensus to the patient you are con-
ronting with a cardiovascular disorder. Again, they are
ot intended to provide an answer to every patient’s ther-
peutic needs. Rather, they are intended as an addition to
he information base of the clinician faced with a decision
bout the best therapy for a cardiovascular disorder. The
xpert clinician integrates all of the information and each
atient’s unique status to decide the best therapy. In every
ase, thorough knowledge of the patient’s history and the
xamination, laboratory, and imaging studies are essential
or high-quality care.I suggest that we define ourselves, first, as clinicians of
he highest order. This means that we commit to provid-
ng individual patient care, that we get involved with our
atients to provide continuity of care, and that we know
ur patients, their history, their family, and their work
nd behaviors—all of which add weight in the clinical
ecision process. Yes, we need to perform procedures, but
e can hope that with new payment reform, we will no
onger be driven to the laboratory to perform procedures
o maintain income, and, instead, we will be properly re-
mbursed for providing continuous care and being excel-
ent clinicians.
The American College of Cardiology is campaigning hard
o move away from volume and intensity as the main criteria
or payment and is emphasizing reimbursement for provid-
ng continuous high-quality care. I believe the result will be
continued provision of excellent care with a reduction in
ost due to reduced overuse of imaging and procedures. In-
ome lost from overuse will be made up by added reim-
ursement for care coordination and quality outcomes, as
ell as some adjustment for underuse of procedures and im-
ging based on guidelines and appropriate use criteria. It is
ikely that we will also increase our clinical activity as the
any millions of uninsured and underinsured patients find
heir way to physicians who will be reimbursed for care that
as previously free.
Do not lose sight of the fact that we are respected as
linicians. Our patients do not see us as imaging doctors
r interventionalists alone. They see us as clinical care
roviders to whom they can come to for advice about
heir medical condition. They expect us to understand
heir condition, to provide or recommend safe, appropri-
te, and efficacious therapy, and to maintain their health
tatus over time. As cardiologists, we need to meet those
xpectations.
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